Cargando…

Can men with prostates sized 80 mL or larger be managed conservatively?

PURPOSE: To analyze the long-term clinical outcomes of men with large prostate sizes of 80 mL and greater who were managed conservatively. MATERIALS AND METHODS: We retrospectively analyzed men with prostate sizes of 80 mL and greater from our electronic hospital database. Clinical parameters such a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Alvin, Lee, Han Jie, Foo, Keong Tatt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577333/ https://www.ncbi.nlm.nih.gov/pubmed/28868508 http://dx.doi.org/10.4111/icu.2017.58.5.359

Ejemplares similares

Safety and effectiveness of high-power thulium laser enucleation of the prostate in patients with glands larger than 80 mL
por: Chang, Ching-Hsin, et al.
Publicado: (2019)

Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?
por: Lee, Alvin, et al.
Publicado: (2016)

AB050. Laparoscopic transperitoneal enucleation of the prostate for benigh prostatic hyperplasia >80 mL
por: Feng, Ning-Han
Publicado: (2015)

Patients with small prostates and low-grade intravesical prostatic protrusion – A urodynamic evaluation
por: Lee, Han Jie, et al.
Publicado: (2017)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

Prostate artery embolization for the treatment of urinary retention caused by large (>80 mL) benign prostatic hyperplasia: Results of 21 patients
por: Yuan, Bing, et al.
Publicado: (2020)

Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates
por: Nguyen, David‐Dan, et al.
Publicado: (2019)

Current consensus and controversies on male LUTS/BPH (part one)
por: Foo, Keong Tatt
Publicado: (2017)

Current consensus and controversies on male LUTS/BPH (part two)
por: Foo, Keong Tatt
Publicado: (2018)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
por: Koc, Gokhan, et al.
Publicado: (2017)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
por: Ahn, Jae Hyun, et al.
Publicado: (2014)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Predicting prostate cancer in men with PSA levels of 4–10 ng/mL: MRI-based radiomics can help junior radiologists improve the diagnostic performance
por: Zhong, Jian-Guo, et al.
Publicado: (2023)

Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes
por: Fagundes, Marcio, et al.
Publicado: (2021)

Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population
por: Wang, Mao Qiang, et al.
Publicado: (2015)

Efficacy of Holmium Laser Enucleation of the Prostate in Patients with a Small Prostate (≤30 mL)
por: Park, Sejun, et al.
Publicado: (2017)

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10 ng/mL
por: Zhou, Yongqiang, et al.
Publicado: (2017)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017)

Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
por: Vasanwala, Farhad Fakhrudin, et al.
Publicado: (2017)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
por: Chiu, Peter Ka-Fung, et al.
Publicado: (2016)

Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
por: Chung, Jae Hoon, et al.
Publicado: (2020)

Successful Management of a Patient with Intraoperative Bleeding of More than 80,000 mL and Usefulness of QTc Monitoring for Calcium Correction
por: Sugiyama, Yuki, et al.
Publicado: (2021)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
por: Fiamegos, Alexandros, et al.
Publicado: (2016)

Clinical Outcome of Endoscopic Enucleation of the Prostate Compared With Robotic-Assisted Simple Prostatectomy for Prostates Larger Than 80 cm(3) in Aging Male
por: Hou, Chen-Pang, et al.
Publicado: (2021)

Comparative Anatomical and Transcriptomics Reveal the Larger Cell Size as a Major Contributor to Larger Fruit Size in Apricot
por: Huang, Mengzhen, et al.
Publicado: (2023)

Of Size and Men: A Call for Larger Trials and Meta-Analyses on Vasopressors During General Anesthesia
por: Biondi-Zoccai, Giuseppe, et al.
Publicado: (2021)

A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL
por: Miyoshi, Yasuhide, et al.
Publicado: (2022)

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
por: Fang, Dong, et al.
Publicado: (2015)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device
por: Lalthanthuami, HT, et al.
Publicado: (2021)

Multisensory Stimulation Can Induce an Illusion of Larger Belly Size in Immersive Virtual Reality
por: Normand, Jean-Marie, et al.
Publicado: (2011)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
por: Iwamoto, Hiroaki, et al.
Publicado: (2019)

Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL
por: Lee, Dong Hoon, et al.
Publicado: (2016)

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4–10 ng/mL and negative digital rectal examination
por: Sriplakich, Supon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r9ime8k0dsl7ovf16rrl5sl6sj